| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 09/07/2001 | WO2001055448A8 Nucleic acids, proteins, and antibodies |
| 09/07/2001 | WO2001055447A8 Nucleic acids, proteins, and antibodies |
| 09/07/2001 | WO2001055440A8 Nucleic acids, proteins, and antibodies |
| 09/07/2001 | WO2001055368A8 Nucleic acids, proteins, and antibodies |
| 09/07/2001 | WO2001055364A8 Nucleic acids, proteins, and antibodies |
| 09/07/2001 | WO2001055355A8 Nucleic acids, proteins, and antibodies |
| 09/07/2001 | WO2001055350A8 Nucleic acids, proteins, and antibodies |
| 09/07/2001 | WO2001055343A8 Nucleic acids, proteins, and antibodies |
| 09/07/2001 | WO2001055328A8 Nucleic acids, proteins, and antibodies |
| 09/07/2001 | WO2001055327A8 Nucleic acids, proteins, and antibodies |
| 09/07/2001 | WO2001055326A8 Nucleic acids, proteins, and antibodies |
| 09/07/2001 | WO2001055326A3 Nucleic acids, proteins, and antibodies |
| 09/07/2001 | WO2001055324A8 Nucleic acids, proteins, and antibodies |
| 09/07/2001 | WO2001055323A8 Nucleic acids, proteins, and antibodies |
| 09/07/2001 | WO2001055322A8 Nucleic acids, proteins, and antibodies |
| 09/07/2001 | WO2001055321A8 Nucleic acids, proteins, and antibodies |
| 09/07/2001 | WO2001055320A8 Nucleic acids, proteins, and antibodies |
| 09/07/2001 | WO2001055319A8 Endocrine related nucleic acids, proteins and antibodies |
| 09/07/2001 | WO2001055318A8 Nucleic acids, proteins, and antibodies |
| 09/07/2001 | WO2001055316A8 Nucleic acids, proteins, and antibodies |
| 09/07/2001 | WO2001055315A8 Nucleic acids, proteins, and antibodies |
| 09/07/2001 | WO2001055314A8 Digestive system related nucleic acids, proteins and antibodies |
| 09/07/2001 | WO2001055312A8 Nucleic acids, proteins, and antibodies |
| 09/07/2001 | WO2001055311A8 Nucleic acids, proteins, and antibodies |
| 09/07/2001 | WO2001055310A8 Nucleic acids, proteins, and antibodies |
| 09/07/2001 | WO2001055309A8 Nucleic acids, proteins, and antibodies |
| 09/07/2001 | WO2001055308A8 Nucleic acids, proteins, and antibodies |
| 09/07/2001 | WO2001055307A8 Nucleic acids, proteins, and antibodies |
| 09/07/2001 | WO2001055304A8 Nucleic acids, proteins, and antibodies |
| 09/07/2001 | WO2001055303A8 Nucleic acids, proteins, and antibodies |
| 09/07/2001 | WO2001055302A8 Nucleic acids, proteins, and antibodies |
| 09/07/2001 | WO2001055301A8 Nucleic acids, proteins, and antibodies |
| 09/07/2001 | WO2001055208A8 Nucleic acids, proteins, and antibodies |
| 09/07/2001 | WO2001055207A8 Nucleic acids, proteins, and antibodies |
| 09/07/2001 | WO2001055204A8 Nucleic acids, proteins, and antibodies |
| 09/07/2001 | WO2001055203A8 Nucleic acids, proteins, and antibodies |
| 09/07/2001 | WO2001055202A8 Nucleic acids, proteins, and antibodies |
| 09/07/2001 | WO2001055201A8 Nucleic acids, proteins, and antibodies |
| 09/07/2001 | WO2001055200A8 Nucleic acids, proteins, and antibodies |
| 09/07/2001 | WO2001055163A8 Nucleic acids, proteins, and antibodies |
| 09/07/2001 | WO2001054733A8 Nucleic acids, proteins and antibodies |
| 09/07/2001 | WO2001054473A8 Nucleic acids, proteins, and antibodies |
| 09/07/2001 | WO2001054472A8 Nucleic acids, proteins, and antibodies |
| 09/07/2001 | WO2001034115A3 Method for encapsulating proteins or peptides in liposomes, liposomes produced using said method, and their use |
| 09/07/2001 | WO2001021761A3 Recombinant adenoviral vectors and their utility in the treatment of various types of fibrosis: hepatic, renal, pulmonary, as well as hypertrophic scars |
| 09/07/2001 | WO2001018202A3 Flint analog compounds and formulations thereof |
| 09/07/2001 | WO2001016294A3 Metal binding compounds and their use in cell culture medium compositions |
| 09/07/2001 | WO2001016289A3 Zymogen activation system |
| 09/07/2001 | WO2001016169A3 RET LIGAND 5 (Retl5) FROM HUMAN AND MOUSE |
| 09/07/2001 | WO2001016163A3 Peptide mixture and vaccine against a chronic viral infection |
| 09/07/2001 | WO2001016135A3 Reverse-turn mimetics and methods relating thereto |
| 09/07/2001 | WO2001015741A3 Genetic suppressor elements against human immunodeficiency virus |
| 09/07/2001 | WO2001014413A3 Polypeptides capable of interacting with the smad peptide and comprising the sequence pp (t/n)k |
| 09/07/2001 | WO2001012812A3 Baff receptor (bcma), an immunoregulatory agent |
| 09/07/2001 | WO2001011937A3 Use of colostrinin, constituent peptides thereof, and analogs thereof for inducing cytokines |
| 09/07/2001 | WO2001009163A3 Improvement of peptide transport by conjugation with bile acids |
| 09/07/2001 | WO2001005823A3 Tryptase inhibitor |
| 09/07/2001 | WO2000078119A3 Cardiomyocytes with enhanced proliferative potential |
| 09/07/2001 | WO2000076528A3 Pharmaceutical preparation containing proteins |
| 09/07/2001 | WO2000075358A3 Mammalian toll homologues and uses thereof |
| 09/07/2001 | WO2000075326A8 Suppressor of cytokine signaling (socs)-3 promoter and methods for its use |
| 09/07/2001 | WO2000071571A3 Fap-activated anti-tumor compounds |
| 09/07/2001 | WO2000050580B1 Composition, methods and reagents for the synthesis of a soluble form of human phex |
| 09/07/2001 | WO2000047618A3 HUMAN β-SECRETASE ENZYME, INHIBITORS AND THEIR COMPOSITIONS AND USES |
| 09/07/2001 | WO2000047203A9 Formulation and system for intra-oral delivery of pharmaceutical agents |
| 09/07/2001 | WO2000002912A3 Disintegrin homologs |
| 09/07/2001 | CA2744921A1 Hybrid expression of neisserial proteins |
| 09/07/2001 | CA2689666A1 Heterologous expression of neisserial proteins |
| 09/07/2001 | CA2402054A1 Antibody inhibiting the binding between gp120 and dc-sign and screening methods |
| 09/07/2001 | CA2401989A1 A method of treatment |
| 09/07/2001 | CA2401963A1 Maurocalcine, analogues thereof and their therapeutical uses |
| 09/07/2001 | CA2401869A1 Agent for the treatment of wounds |
| 09/07/2001 | CA2401775A1 Diagnostics and therapeutics for glaucoma |
| 09/07/2001 | CA2401716A1 Methods for promoting production of myelin by schwann cells |
| 09/07/2001 | CA2401696A1 Therapeutic compositions for pulmonary delivery |
| 09/07/2001 | CA2401683A1 Design and discovery of protein based tnf-.alpha. variants for the treatment of tnf-.alpha. related disorders |
| 09/07/2001 | CA2401670A1 Human enzyme molecules |
| 09/07/2001 | CA2401665A1 Methods for treating, screening for, and detecting cancers expressing vascular endothelial growth factor d |
| 09/07/2001 | CA2401660A1 Lipid metabolism enzymes |
| 09/07/2001 | CA2401652A1 High potency recombinant antibodies and method for producing them |
| 09/07/2001 | CA2401633A1 Modulation of pleiotrophin signaling by receptor-type protein tyrosine phosphatase .beta./.zeta. |
| 09/07/2001 | CA2401628A1 Sulfated ccr5 peptides for hiv-1 infection |
| 09/07/2001 | CA2401621A1 Modulation of the activity of the endothelial cel surface receptor ecrtp/dep-1 in the regulation of angiogenesis |
| 09/07/2001 | CA2401613A1 Amino acids sequencing facilitating penetration of a substance of interest into cells and/or cell nuclei |
| 09/07/2001 | CA2401607A1 Methods for selectively modulating survivin apoptosis pathways |
| 09/07/2001 | CA2401606A1 Caspase-inhibitory-factor (cif) and uses thereof |
| 09/07/2001 | CA2401550A1 Casein derived peptides and uses thereof in therapy |
| 09/07/2001 | CA2401453A1 G-proteins coupled receptor related polypeptides |
| 09/07/2001 | CA2401405A1 Medicament for viral diseases |
| 09/07/2001 | CA2401343A1 A method of treatment and prophylaxis |
| 09/07/2001 | CA2401175A1 Chordin-like-2 molecules and uses thereof |
| 09/07/2001 | CA2401173A1 G12l, a gene associated with the thermal response |
| 09/07/2001 | CA2401022A1 Methods for treating fsh related conditions with gnrh antagonists |
| 09/07/2001 | CA2400679A1 Human schizophrenia gene |
| 09/07/2001 | CA2400595A1 Human schizophrenia gene |
| 09/07/2001 | CA2397502A1 Serine/threonine phosphatase polynucleotides, polypeptides, and antibodies |
| 09/06/2001 | WO2001064715A2 Memno peptides, a process for their preparation and their use |
| 09/06/2001 | US20010020012 Administering ligands for growth horomne receptors |
| 09/06/2001 | US20010020010 Polypeptide |
| 09/06/2001 | US20010020006 Dipeptidyl peptidase; antidiabetic agents |